A robust label-free workflow for the immunoglobulin G subclass site-specific N-glycopeptides and the glycosylation of IgG 2 correlated with colorectal cancer.

Journal: Talanta
Published Date: May 22, 2025

Abstract

Immunoglobulin G (IgG) subclasses glycosylation reflects the progression of colorectal cancer (CRC). Precise identification of IgG subclass-specific glycopeptides is a critical step. However, it is still hard to achieve a one-step mass spectrometry (MS) since all four subclasses of IgG (IgG1- IgG4) contain several possible N-glycans in the Fc regions with a highly similar amino acid sequence. In this study, we set up a label-free workflow to quantify IgG subclass site-specific N-glycopeptides in a single run MS based on the poly (glycerol methacrylate) @ chitosan (PGMA@CS) nanomaterial enrichment. The nanomaterial was used to purify glycopeptides effectively and the LC-SCE-HCD-MS/MS was used to obtain the peptide and glycan fragment in one single run MS. Through our workflow, all four subtypes of IgG glycopeptides were distinguished. For the first time, a total of 89 biantennary IgG subclass-specific N-glycopeptides were detected for quantification in 50 CRC patients and 66 healthy individuals. We have found that the decrease in galactosylation, fucosylation of sialylated glycans, sialylation of IgG2-Fc was associated with colorectal cancer. The results demonstrated that the glycopeptides of IgG-Fc are associated with CRC and potential to serve as noninvasive biomarkers. And it implies that the workflow can also accommodate the precise high-throughput identification of intact N-glycopeptides at the proteome scale.

Authors

  • Yuan Wang
    State Key Laboratory of Soil and Sustainable Agriculture, Changshu National Agro-Ecosystem Observation and Research Station, Institute of Soil Science, Chinese Academy of Sciences, Nanjing, China.
  • Ningfeng Liu
    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China; Peking-Tsinghua Center for Life Science (CLS), Peking University, Beijing, 100871, China.
  • Yang Zou
  • Jianzheng Jie
    Department of Colorectal Surgery, China-Japan Friendship Hospital, Beijing, 100029, China. Electronic address: jianzhengjie@sohu.com.
  • Zhenming Liu
    State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 100191 Beijing, P. R. China.
  • Xiajuan Zou
    Medical and Healthy Analysis Center, Beijing Key Laboratory of Tumor Systems Biology, Peking University, Beijing, 100191, China. Electronic address: zouxj@bjmu.edu.cn.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals